Navigation Links
PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million
Date:3/7/2011

crease over the approximately 48,800 patients who were on therapy at the end of December 2009 and that cumulatively 78,800 patients have been treated with Tysabri in the post-marketing setting.  Tysabri royalties are determined at a flat rate as a percent of sales regardless of location of manufacture or sale.

The sales information presented above is based on information provided by PDL's licensees in their quarterly reports to the Company as well as from public disclosures made by PDL's licensees.

About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking Statements This press release contains forward-looking statements. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

  • The expected rate of growth in royalty-bearing product sales by PDL's existing licensees;
  • The relative mix of royalty-bearing Genentech products manufactured and sold outside the U.S. versus made or sold in the U.S.;
  • The ability of our licensees to receive regulatory approvals to market and launch new royalty-bearing products and whether such products, if launched, wil
    '/>"/>

  • SOURCE PDL BioPharma, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
    4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
    5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
    6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
    7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
    8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
    9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
    10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
    11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces that ... catalogue: Baby Food Eastern Europe 2014 ... Food Eastern Europe 2014" is a new report by ... in Eastern Europe , key segments, ... This report also examines trends which are currently affecting ...
    (Date:8/27/2014)... Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: ... pharmaceutical company with the largest cardio-cerebral vascular ("CCV") ... prescription drug market, today announced the unaudited consolidated ... the "Group") for the six months ended 30 ... the Six months ended 30 JuneKey Income Statement ...
    (Date:8/27/2014)... 2014 Kewaunee Scientific Corporation (Nasdaq: ... its quarterly cash dividend by 9% to twelve cents ... beginning with the dividend payable on September 22, 2014 ... on September 8, 2014. About Kewaunee ... Scientific Corporation is a recognized global leader in the ...
    Breaking Medicine Technology:Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
    ... , July 13 Hospira, Inc. ... of clinical information and medication delivery technologies, today announced ... surveillance system helped clinicians at Memorial Hospital Miramar ... in infection-control interventions. The hospital, which used TheraDoc to ...
    ... BEIJING , July 13 /PRNewswire-Asia-FirstCall/ ... in the development, assembly,marketing and sale of medical devices and homecare ... an emergency ventilator product line,(QS-100A series) from Beijing Qiumanshi Technology Co., ... , , ...
    Cached Medicine Technology:Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 2Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 3Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 4Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 5Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 6Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 2Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 4
    (Date:8/27/2014)... 27, 2014 The extensive polling ... by healthcare research group Black Book Rankings uncovers ... adequately staffed, supplied or built to care for ... initiated this annual survey to gain stakeholder insight ... control, epidemiology and emergency preparedness systems,” said Doug ...
    (Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- Pouring half a glass ... much, according to a new study. Researchers asked 74 college ... settings and from bottles that had varying amounts of wine in ... normal. Those who had a "rule of thumb" about how ... glass or two fingers from the top -- poured less wine ...
    (Date:8/27/2014)... 27, 2014 Connor Sports has ... World Cup in Spain at the Barcelona, Bilbao, Gran ... FIBA Equipment & Venue Centre Partner since 1994 and Official ... six courts will bear the Connor Sports logo and tagline ... globe on the ESPN broadcasts of the FIBA World Cup. ...
    (Date:8/27/2014)... TX (PRWEB) August 27, 2014 Picture, if ... not Holmes and Watson but more of a Mr. Inside, ... Davis, in terms of personalities and world view. This Mr. ... University of Texas at Austin, and Mr. Outside was an ... family physician, his new girlfriend, and a gaggle of teenagers ...
    (Date:8/27/2014)... NC. SonaCare Medical, LLC, the global ... sales of 15 HIFU devices over the past twelve ... for the company’s ablation technology. , “It is ... achieved over the past year, especially since we are ... our most active sales period,” says Mike Klein, CEO ...
    Breaking Medicine News(10 mins):Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2
    ... to treat childhood cholera. ,Researchers in Bangladesh have ... effectively with a single dose // of the antibiotic ... The Lancet., ,Cholera is a major global health ... In the resource-limited countries where cholera occurs, any reduction ...
    ... issue of JAMA says that heart patients who are ... of medications. ,Heart failure affects more than 5 ... States and is associated with a high death rate, ... to reduce the risk of illness and death from ...
    ... Professor Alice Sigurdson and Colleagues has reported the dosage ... which increases the risk of thyroid cancer. ... were treated for thyroid cancer during their childhood. The ... risk of developing thyroid cancer and there seems to ...
    ... elevated to the level of health friends. In the same ... to have benefits for coronary heart disease. ,New research ... effect on heart disease and stroke. A research team in ... that drinking a cup of cocoa can prevent potentially fatal ...
    ... be less at risk from developing the dreaded disease ... the recent issue of Archives of Neurology. ,In ... the course of a MS-like disease in animals, suggesting ... the postpartum period afterward, both states associated with profound ...
    ... Risk of bone fracture in postmenopausal women might be reduced ... in the September issue of the journal Archives of Internal ... rate of three to five percent per year for about ... high risk for bone fracture, according to background information in ...
    Cached Medicine News:Health News:Heart Patients More At Risk Get Fewer Medicines 2Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Cocoa: Doesn’t Taste Like Red Wine But Has Benefits Like It 2Health News:Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women 2
    ... Uniflex® Nailing System was to develop a ... the widest possible variety of femoral fractures. ... the system takes full advantage of our ... healing combined with modern materials and biomechanical ...
    ... Quad 4™ Intramedullary Nailing System was to ... used for the widest possible variety of ... were to minimize the number of implants ... system that could address antegrade or retrograde ...
    ... latest in the Magnes line of biomagnetometer systems, ... full cortical coverage, provides the highest detector density ... of a wide range of neuronal activity. The ... detector configurations and can be equipped with radial ...
    ... easy voice access to information on the ... easy and intuitive, enabling you to interact ... With the VoiceBox Voice Information Retrieval Software, ... of subjects and topics and receive up-to-date ...
    Medicine Products: